{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:11:59Z","timestamp":1793747519339,"version":"4.6.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ajoc.2024.101993","type":"journal-article","created":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T10:15:02Z","timestamp":1705227302000},"page":"101993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Mitomycin intravascular chemoembolization (MICE) to treat corneal vascularization prior to penetrating keratoplasty"],"prefix":"10.1016","volume":"33","author":[{"given":"Neal","family":"Rangu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1090-5025","authenticated-orcid":false,"given":"Kamran M.","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajoc.2024.101993_bib1","article-title":"Epidemiology of corneal neovascularization and its impact on visual acuity and sensitivity: a 14-year retrospective study","volume":"14","author":"Lasagni Vitar","year":"2021","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.ajoc.2024.101993_bib2","first-page":"182","article-title":"Clinical correlates of common corneal neovascular diseases: a literature review","volume":"8","author":"Abdelfattah","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.101993_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40662-017-0094-6","article-title":"Therapeutic approaches for corneal neovascularization","volume":"4","author":"Feizi","year":"2017","journal-title":"Eye Vis (Lond)"},{"issue":"7","key":"10.1016\/j.ajoc.2024.101993_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s004170100313","article-title":"Impact of short-term versus long-term topical steroids on corneal neovascularization after non-high-risk keratoplasty","volume":"239","author":"Cursiefen","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajoc.2024.101993_bib5","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1097\/ICO.0b013e31825ec407","article-title":"Recurrence of corneal neovascularization associated with lipid deposition after subconjunctival injection of bevacizumab","volume":"32","author":"Chu","year":"2013","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.ajoc.2024.101993_bib6","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","article-title":"Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis","volume":"117","author":"Bachmann","year":"2010","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajoc.2024.101993_bib7","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s10792-022-02240-6","article-title":"Initial outcomes of mitomycin intravascular chemoembolization (MICE) for corneal neovascularization","volume":"42","author":"Mimouni","year":"2022","journal-title":"Int Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajoc.2024.101993_bib8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/ICO.0b013e318201405a","article-title":"Treatments for corneal neovascularization: a review","volume":"30","author":"Gupta","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2024.101993_bib9","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajoc.2024.101993_bib10","first-page":"89","article-title":"Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab","volume":"12","author":"Anand","year":"2019","journal-title":"Int Med Case Rep J"},{"issue":"2","key":"10.1016\/j.ajoc.2024.101993_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","article-title":"Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)","volume":"10","author":"Stevenson","year":"2012","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajoc.2024.101993_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.87.1.101","article-title":"Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation","volume":"87","author":"Cursiefen","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajoc.2024.101993_bib13","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/bjophthalmol-2014-304891","article-title":"Fine needle diathermy occlusion of corneal vessels","volume":"98","author":"Faraj","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajoc.2024.101993_bib14","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/ICO.0b013e31823f8f7a","article-title":"Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs","volume":"31","author":"Koenig","year":"2012","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.ajoc.2024.101993_bib15","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s00417-021-05546-w","article-title":"Three-year follow-up of high-risk keratoplasty following fine-needle diathermy of corneal neovascularization combined with bevacizumab","volume":"260","author":"Mestanoglu","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.101993_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/taap.1995.1012","article-title":"Toxicity of mitomycin C toward cultured pulmonary artery endothelium","volume":"130","author":"Hoorn","year":"1995","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"10.1016\/j.ajoc.2024.101993_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.thromres.2004.09.001","article-title":"In vitro effect of cyclosporin A, mitomycin C and prednisolone on cell kinetics in cultured human umbilical vein endothelial cells","volume":"115","author":"Seki","year":"2005","journal-title":"Thromb Res"},{"issue":"7","key":"10.1016\/j.ajoc.2024.101993_bib18","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3928\/1081-597X-20070901-14","article-title":"Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy","volume":"23","author":"Goldsberry","year":"2007","journal-title":"J Refract Surg"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624000033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624000033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T23:36:56Z","timestamp":1721173016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993624000033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":18,"alternative-id":["S2451993624000033"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.101993","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitomycin intravascular chemoembolization (MICE) to treat corneal vascularization prior to penetrating keratoplasty","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.101993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101993"}}